The p53 gene therapy Advexin has demonstrated positive results in locally-advanced breast cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1468, 2004-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

P53 Gene Therapy Sensitizes Resistant Breast Cancer Cells to Doxorubicin Chemotherapy

By Kumar Ajay   Palakurthi Srinath  

Drug Delivery Letters, Vol. 3, Iss. 3, 2013-12 ,pp. : 165-174

Bentham Science Publishers

Access to resources Recommend Favorite

P53 Gene Therapy Sensitizes Resistant Breast Cancer Cells to Doxorubicin Chemotherapy

By  

Drug Delivery Letters, Vol. 3, Iss. 3, 2013-12 ,pp. : 165-174

Bentham Science Publishers

Access to resources Recommend Favorite

Non-viral Delivery Systems for the Application in p53 Cancer Gene Therapy

By  

Current Medicinal Chemistry, Vol. 22, Iss. 35, 2015-11 ,pp. : 4118-4136

Bentham Science Publishers

Access to resources Recommend Favorite

Sorafenib in locally advanced or metastatic breast cancer

By Gradishar William J  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 8, 2012-08 ,pp. : 1177-1191

Informa Healthcare

Access to resources Recommend Favorite

Ixabepilone: In Locally Advanced or Metastatic Breast Cancer

By Moen Marit D.  

Drugs, Vol. 69, Iss. 11, 2009-07 ,pp. : 1471-1481

Adis International

Access to resources Recommend Favorite